Cabaletta Bio Inc (CABA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -167,856 | -125,937 | -81,071 | -35,943 | -115,864 |
| Depreciation Amortization | 12,320 | 1,059 | 1,227 | 652 | 3,690 |
| Accounts payable and accrued liabilities | 1,550 | 3,256 | 2,186 | 1,591 | 1,011 |
| Other Working Capital | -379 | 1,233 | 1,018 | -3,047 | 1,611 |
| Other Operating Activity | 23,285 | 24,652 | 15,412 | 5,945 | 21,330 |
| Operating Cash Flow | $-131,080 | $-95,737 | $-61,228 | $-30,802 | $-88,222 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,229 | -1,024 | -946 | -785 | -2,211 |
| Purchase Of Investment | -49,037 | -99,037 | -49,035 | N/A | 49,500 |
| Investing Cash Flow | $-50,266 | $-100,061 | $-49,981 | $-785 | $47,289 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6,261 | -4,349 | -3,554 | -552 | -897 |
| Common Stock Issued | 106,608 | 96,364 | 96,375 | N/A | 12,574 |
| Financing Cash Flow | $100,347 | $92,015 | $92,821 | $-552 | $11,677 |
| Exchange Rate Effect | 19 | 27 | 38 | 7 | -20 |
| Beginning Cash Position | 163,962 | 163,962 | 163,962 | 163,962 | 193,238 |
| End Cash Position | 82,982 | 60,206 | 145,612 | 131,830 | 163,962 |
| Net Cash Flow | $-80,980 | $-103,756 | $-18,350 | $-32,132 | $-29,276 |
| Free Cash Flow | |||||
| Operating Cash Flow | -131,080 | -95,737 | -61,228 | -30,802 | -88,222 |
| Capital Expenditure | -1,229 | -1,024 | -946 | -785 | -2,211 |
| Free Cash Flow | -132,309 | -96,761 | -62,174 | -31,587 | -90,433 |